Background: iLOV is a fluorescent flavoprotein engineered from the plant blue-light receptor phototropin. Results: Structures reveal altered proteinchromophore interactions within the flavin-binding cavity of iLOV compared to its progenitors. Directed evolution further anchored the chromophore to increase iLOV photostability by an order-of-magnitude. Conclusion: Improving iLOV photostability by constraining its fluorophore establishes a framework for fine-tuning fluorescence. Significance: Enhanced photostability increases iLOV utility as an oxygen-independent fluorescent reporter.
Fluorescent proteins (FPs) have revolutionized the imaging of dynamic processes within living cells (1) . Despite their wide range of applications, however, Green Fluorescent Protein (GFP) and its derivatives have three key limitations. First, their use is restricted to aerobic systems, as chromophore formation is oxygen dependent (2) . Second, for certain applications, the relatively large size (~25 kDa) of GFP is limiting (3) . Generation of smaller GFP derivatives is unlikely, as the 11-stranded β-barrel structure of the protein is intrinsic to its function (2) . Third, GFP fluorescence is unstable at pH < 5, prompting the development of pH-resistant variants (1) . As a result of these factors, there is considerable interest in developing alternative protein-based fluorescent probes. LOV (Light, Oxygen or Voltage) domains derived from plant and bacterial blue-light receptors exhibit considerable potential as green fluorescent probes with advantages over the current GFP technology (3) (4) (5) . LOV domains form a subset of the versatile Per-ARNT-Sim (PAS) superfamily (6, 7) characterized by the prototypic photoactive yellow protein (PYP) structure, which has yielded key information on photocycle intermediates (8) and conformational changes (9) . LOV domains typically bind FMN non-covalently as a UV-A/blue light-absorbing chromophore (10) . Upon photoexcitation, LOV domains undergo a reversible photocycle involving the formation of a covalent bond between the FMN chromophore and a conserved cysteine residue within the protein (11) reminiscent of the cysteine connection in PYP (12) . This light-induced covalent flavin adduct thermally decays to the dark state within tens to thousands of seconds depending on the specific LOV domain environment (13) .
The FMN chromophore provides the LOV domain with a weak intrinsic green fluorescence when excited with UV-A/blue light (14, 15) . Mutagenesis of the active-site cysteine residue abolishes LOV-domain photochemistry and increases its fluorescence (11, 16) , making photochemically-inactivated LOV domains useful as in vivo reporters. For example, owing to their small size (~11 kDa), LOV-based FPs outperform GFP as reporters for monitoring local and systemic infections of plant RNA viruses, and confer improved functionality when fused to viral proteins essential for movement (3) . Furthermore, the dependence on a cellular cofactor for fluorescence does not limit the use of the LOV domain in subcellular targeting in plant or mammalian cells (3, 5) .
LOV-based FPs offer other favorable attributes besides their smaller size. LOV-mediated fluorescence is stable over a wide pH range in vitro (16) and may circumvent the pH sensitivity commonly associated with GFP-related FPs (2) . Similarly, LOV fluorescence, unlike that of GFP, is independent of molecular oxygen (4, 5) . This property is particularly advantageous for studies of biological processes that operate under anaerobic conditions. Consequently, LOV-based FPs hold promise over GFP and related protein scaffolds as real-time reporters for probing cell biomass and product formation in micro and macro bioreactors (17, 18) . More recently, a LOV-based FP that efficiently generates singlet oxygen upon bluelight illumination has been reported that can facilitate correlative light and electron microscopy of intact tissues (5) .
Photochemically inactivated LOV-domains are inherently fluorescent, but additional mutagenesis was necessary to generate variants with improved fluorescence and photostability (3, 5) . One such variant, designated iLOV, contains multiple amino acid changes as a consequence of molecular evolution (3) . Structural analysis of this variant is therefore important to understand the impact of these substitutions on protein-chromophore interactions that fine-tune fluorescence.
Here, we uncover a molecular framework underlying the enhanced fluorescent properties of the iLOV reporter by comparative structural analysis. Moreover, we demonstrate that further fine-tuning of the iLOV-scaffold can be achieved through DNA shuffling to yield variants with increased photostability. Together, these results enhance our understanding of proteinchromophore interactions within the LOV-scaffold and how these can be altered to control its fluorescence in pre-determined ways.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification. LOVdomain constructs based on the sequence of the LOV2 domain of Arabidopsis thaliana phototropin 2 (NCBI Accession NP_851211.1; amino acids 387-496) were expressed in Escherichia coli and purified as fusions to glutathione-S-transferase (GST) using pGEX-6P-1 or pGEX-4T-1 (GE Healthcare). Amino acid substitutions were introduced using the QuikChange Site-directed Mutagenesis kit (Agilent) and verified by DNA sequencing. Transformed E. coli were grown at 37ºC; protein expression was induced by addition of isopropyl β -D-1-thiogalactopyranoside (IPTG) to 0.4 mM at OD 600 0.6-0.8. After overnight incubation at 24ºC, cells were harvested by centrifugation for 15 min at 5000 x g and the pellet resuspended in solution containing 50 mM TrisHCl, pH 8.0. Cells were sonicated on ice five times for 1 min with regular resting intervals. The clarified lysate obtained after centrifugation at 12000 x g for 1 h was applied to a GST resin column and washed with 5 bed volumes of solution containing 50 mM Tris-HCl, pH 8.0. Bound protein was eluted with reduced glutathione in 50 mM Tris-HCl (pH 8.0) and 250 mM NaCl. Selected fractions were pooled and treated with PreScission (GE Healthcare) or Thrombin (Sigma) protease overnight at 4ºC. After cleavage, the protein was dialyzed against 50 mM Tris-HCl, pH 8.0 and 50 mM NaCl and the cleaved GST tag removed using the GST purification resin column. The protein was further purified by gel filtration on Sephacryl S-100 (GE Healthcare), eluted with a solution of 50 mM Tris-HCl, pH 8.0 and 50 mM NaCl, and concentrated to 20 mg/ml. Protein Crystallography. Crystals were obtained by hanging drop vapor diffusion against a reservoir solution at 20ºC. Drops contained 1 µl each of the concentrated protein and the reservoir solution: 37.5% methoxypolyethylene glycol 2000 (MPEG 2K), 0.2 M imidazole malate pH 4.8 for wild-type LOV2, C426A and iLOV (form I), 25% PEG 3350, 5% PEG 400, 0.1M sodium acetate pH 5.5 for iLOV (form II) and 25% MPEG 2K, 0.2 M imidazole malate pH 8.6 for phiLOV2.1. Crystals were flash cooled in liquid nitrogen before data collection. X-ray diffraction data were collected at the SIBYLS beamline 12.3.1 at the Advanced Light Source (ALS), Lawrence Berkeley National Lab, Berkeley CA or at the Stanford Synchrotron Research Laboratory (SSRL) beamline 11-1, and processed with HKL2000 (19). The structure of iLOV crystal form I was determined by molecular replacement, using PDB 2V1A as a search model. Phaser (20) gave a clear solution with a LogLikelihood Gain of 2385 while the runner-up was 959. This structure was used to determine phases for the remaining structures. Models were fitted manually with COOT (21) and refined with Phenix (22) for phiLOV and Refmac (23) for the others. Diffraction data collection and refinement statistics are summarized in Table S1 .
Mutagenesis and Screening.
Mutagenesis and DNA shuffling were performed as described previously (3) . Ligation reactions were transformed into electrocompetent BL21(DE3) E. coli (Novagen), plated on LB-agar containing 100 µg/ml ampicillin (Sigma) and 100 µ M IPTG (Roche) and incubated in darkness at 30ºC for 24 hours, as described (24) . LOV-associated fluorescence was visualized with a Blak-Ray lamp (UVP). Colonies were photobleached using a Bluephase 16i dental curing light (Ivoclar Vivadent) for 5-10 s (λmax 443 nm, half bandwidth 10 nm; 0. 16 
RESULTS

Overall Structural Comparisons of iLOV with its
Progenitors. iLOV was engineered from the LOV2 domain of Arabidopsis thaliana phototropin 2, for which structural information is lacking. To better understand the structural basis for iLOV fluorescence, we determined and compared X-ray crystallographic structures of iLOV with its wildtype progenitor (residues 387-496 of Arabidopsis phototropin 2 (WT), and its photochemicallyinactivated C426A variant, from which iLOV was derived (3). To aid comparisons, we obtained isomorphous crystals belonging to space group P4 3 2 1 2 for all three proteins under identical conditions, with one molecule per asymmetric unit (Table S1 ). Structures were determined and refined to 1.8 Å resolution for iLOV and 1.7 Å resolution for WT and C426A. All exhibit the LOV/PAS-fold comprising five anti-parallel β -strands (Aβ, Bβ, Gβ, Hβ, and Iβ) framed by four α-helices (Cα, Dα, Eα and Fα) (Fig. 1A) . The edge of the FMN isoalloxazine ring rests on the Hβ and Iβ-strands, while the ring itself is sandwiched between the Eα and Fα-helices (Fig. 1A) . The overall structure of iLOV exhibits noticeable differences from those of WT and C426A, particularly within the flexible loop extension (residues 476-483) between Hβ and Iβ (Fig. 1B) . iLOV contains the following substitutions, relative to WT: C426A; S409G; F470L; S394T, I452T and M475V (3). The M475V substitution in iLOV is located at the edge of the flexible Hβ/Iβ loop extension (Fig. 1B) and likely contributes to the observed structural difference in this region. The S409G and I452T mutations in iLOV also appear to introduce subtle structural changes associated respectively with Cα and Dα, and with Gβ and preceding Fα of the LOV scaffold (Fig. 1B) .
Mapping crytallographic temperature factors (B-values) onto protein structures has proven useful for observing differences in mobility with functional implications (26) . When B-values were mapped onto the WT structure ( Fig. 2A) , we found that core flexible regions (Cα, Dα and adjacent β-hairpin) matched regions of the archetypal LOV/PAS-domain protein PYP that showed increased flexibility during light-induced signaling, as measured by enhanced hydrogen/deuterium exchange mass spectrometry (9) . B-value-mapping on the iLOV structure (Fig.  2B) showed a similar pattern, but suggested more order in the vicinity of the chromophore and less overall flexibility.
The iLOV structure is more compact than its progenitors (Table S2) , consistent with enhanced rigidity. The reduced molecular volume of iLOV does not appear to result from crystal packing, as the same property was observed for different nonisomorphous crystals (form II; 1.2 Å) (Table S1, S2). Thus, both iLOV crystal forms provide evidence for compaction relative to its progenitors. The presence of two molecules per asymmetric unit in form II crystals (Table S1) suggests that iLOV has the propensity to dimerize. However, iLOV was found to be monomeric by size exclusion chromatography (Fig. S1 ).
iLOV Exhibits Altered Protein-chromophore Interactions. Given the overall changes evidenced in both iLOV structures, we paid particular interest to structural differences that impacted protein backbone and/or side chain interactions with the FMN chromophore.
Introduction of the C426A mutation does not appear to alter the backbone position of Eα (Fig.  1B) . iLOV contains two additional changes within the vicinity of the FMN isoalloxazine ring: S394T and F470L. Ser394 faces away from the isoalloxazine ring (Fig. 3A, B ) and hydrogen bonds with Asn401 in the structures of WT and C426A. In iLOV, the methyl group of Thr394 'crowds' this region adjacent to the isoalloxazine ring, thereby restricting the mobility of the FMN (Fig. 3C) . The F470L mutation, located on the opposite side of the isoalloxazine ring, imparts further steric restrictions on the FMN (Fig. 3C) . Notably, Leu472 (which is not mutated in iLOV) becomes reoriented or 'flipped' towards the isoalloxazine ring to accommodate contacts with the FMN and Leu470 (Fig. 3C) .
Mutations in Leu472 were introduced to further probe its contribution to iLOV fluorescence. Substitution to smaller valine reduced iLOV fluorescence in liquid cultures of E. coli to a level comparable to C426A, whereas mutation to sizeequivalent isoleucine was without effect (Fig. 4A) . Neither replacement enhanced the photostability of iLOV over C426A when irradiated with mediumintensity blue light (0.06 W/cm 2 ; Fig. 4B ) indicating that side-chain rotation of Leu472 contributes to the improved fluorescence of iLOV over C426A, but has little impact on photostability.
Superposition of WT, C426A and iLOV structures revealed that the terminal phosphate and ribityl side chain of the FMN chromophore is shifted in iLOV away from the flanking Fα-helix (Fig. 5A) . The terminal phosphate of the FMN is typically anchored in LOV domains by conserved salt bridges. In WT, Arg427 at the Eα-helix links Asp400 in the Aβ/Bβ loop to the FMN phosphate, which is tethered at the other side by Arg443 of the Fα-helix (Fig. 5B) . Shifting of the FMN phosphate and ribityl tail in iLOV is coupled to side chain movements of Arg443 and Glu440 in the Fα-helix that restrict the phosphoribityl tail of the FMN (Fig. 5C ). Together, these changes tend to rigidify or reduce the dynamics of the chromophore. Enhancements in iLOV Photostability. Besides being 10-fold brighter than WT, iLOV also exhibits greater photostability (3) . With this in mind, we wished to test directed evolution strategies to further fine-tune iLOV for photostability enhancements.
An in vivo screening method was developed in E. coli to assay for improvements in iLOV photostability. When iLOV is expressed in liquid culture, its fluorescence can be photobleached (Fig. 5A ) by using a high-intensity blue light source (0.16 W/cm 2 ). Consistent with our previous findings in tobacco epidermal cells (3), iLOV fluorescence in E. coli is fully recoverable following photobleaching (Fig. 6A) , with a halfmaximal recovery time of 75 s (Fig. 6B) . Reversible photobleaching of iLOV was also detected in E. coli colonies grown on agar medium (Fig. 6C) , providing a medium-throughput means to screen for variants with resistance to photobleaching.
Random mutagenesis was employed to generate a library of iLOV-encoding sequences that were screened for photostability improvements. Fourteen variants from the first round of screening were selected and subjected to further analysis. Comparative in vivo photobleaching measurements in liquid cultures confirmed that all variants selected showed improved photostability compared to iLOV (Fig.  6D) . These variants were designated phiLOV1 (for photostable iLOV, round 1).
phiLOV1.3 and phiLOV1.6 displayed notable blue shifts of ~10 nm in their fluorescence emission compared to iLOV (Fig. S2 ). Sequence analysis of phiLOV1 variants (Fig. S3 ) revealed several amino acids changes that occurred at high frequency (Table S3 ). These included mutations in Asn425 and Glu430, which hydrogen bond with the ribityl side of the FMN chromophore. Point mutations of these residues were introduced into iLOV to determine their individual impacts on photostability. Both N425S and Q430R mutations improved iLOV photostability in vivo (Fig. S4A) . However, when these mutations were combined, a severe reduction in fluorescence was observed (Fig. S4B) as a consequence of reduced flavin binding (Fig. S4C ). PhiLOV1 variants showing > 4-fold photostability enhancements (Fig. 6D) were therefore selected as templates for a second round of mutagenesis and DNA shuffling, in an attempt to further enhance photostability.
Isolation of iLOV Variants with 10-fold Enhancements in Photostability.
Screening after a second round of mutagenesis on pooled phiLOV1 variants 1.1, 1.3, 1.6, 1.9, 1.12, 1.13 and 1.18 ( Fig.  6D) produced further photostability enhancements. These variants, designated phiLOV2, showed ~10-fold enhancements in photostability compared to iLOV in liquid culture (Fig. 7A) . The improved photostable properties were also clearly visible in E. coli grown on solid agar medium (Fig. 7B) .
Sequence analysis of phiLOV2 variants revealed multiple substitutions throughout the domain (Fig. S5) . These mutations, however, had little impact on the level of in vivo fluorescence of phiLOV2 variants compared to iLOV (Fig. 7C) . Subtle differences were seen in the fluorescence emission spectra for particular variants (phiLOV2.1; 2.9), suggesting alterations within their chromophore-binding environment (Fig. 7D) .
phiLOV2.1 was selected for codon optimization to determine whether its improved photostability could be detected in mammalian cells. Although the transfection efficiency for phiLOV2.1 was slightly reduced compared to that for iLOV, both proteins exhibited robust fluorescence in BSC1 monkey kidney cells (Fig.  7E) . However, iLOV fluorescence decreased rapidly after repeated exposures, to reach a steadystate level close to background. In constrast, phiLOV2.1 showed a greater resistance to photobleaching (Fig. 7F) demonstrating that its photostable properties were extendable to mammalian cells. Structural Characterization of phiLOV2.1. Confirmation of its enhanced photostability in mammalian cells prompted us to determine the structure of phiLOV2.1. Consistent with providing optimal structural comparisons between iLOV and its progenitors, we prepared crystals of phiLOV2.1 belonging to space group P4 3 2 1 2., then solved and refined its structure to 1.4 Å resolution (Table S1 ).
phiLOV2.1 contains 6 mutations compared to iLOV ( Fig. S5 ; N390S, N401Y L422M, Q468R, E471G and D491V). Nonetheless, the overall structure of the PAS/LOV-fold is maintained in phiLOV2.1 as are FMN-binding features found in iLOV, including side chain rotation of Leu472 (Fig. 8A) .
The crowding effect in iLOV as a consequence of the S394T mutation (Fig. 3C) is similarly preserved in phiLOV2.1, in spite of the N401Y mutation (Fig. 8A) . Introduction of a tyrosine ring at position 401 (Fig. 8A) causes the side chain of Phe485 to move closer and more parallel to the ring of Pro474 (Fig. 8B) . As a result, the aromatic side chains of Tyr401 and Phe485 in phiLOV2.1 cap the hydrophobic end of the FMN isoalloxazine ring, and further sequester it from solvent. In addition Val392, Ile446, Leu472 and the methyl group of Thr394 provide an enriched hydrophobic environment surrounding the isoalloxazine ring. The fluorophore is more constrained in phiLOV2.1 and iLOV than in their progenitors, consistent with decreased B-values suggesting enhanced rigidity (Fig. S6) . In contrast to iLOV, positions of Arg397 and Asp477 are altered to gain a hydrogen bond that bridges the edge of the FMN-binding cleft (Fig. 8B) .
All phiLOV2 variants contain the N390S mutation near the N-terminus of the domain (Fig.  S5) . In phiLOV2.1, the side chain of S390 introduces a hydrogen bond with neighboring Gln489 (Fig. 8C) , which anchors the FMN at the O4 position in iLOV and its predecessors (Fig. 3) . Consequently, interactions between Gln489 and the FMN chromophore are altered in phiLOV2.1 by impacting the chemical environment surrounding the hydrophilic side of FMN isoalloxazine ring.
DISCUSSION
FPs based on flavin-binding LOV domains represent attractive candidates as fluorescent reporters, owing to their small size and innate ability to acquire their ubiquitous organic cofactor from the cellular environment. Indeed, their utility as fluorescent biomarkers has already been demonstrated (3) (4) (5) . Hence, characterization of these flavin-based FPs at the biophysical and structural level to better understand their fluorescent properties is invaluable for extending their utility.
The comparative structural and mutational analyses presented here provide a molecular basis for the improved photochemical properties of iLOV and its new photostable derivative phiLOV. Thr394 and Leu470 directly pack against the chromophore (Fig. 3C) . Leu472 contributes to iLOV fluorescence (Fig. 4A ) and flips its side chain to pack more closely with the FMN chromophore and Leu470 (Fig. 3C) . Repositioning of a conserved salt bridge between Arg443 and the FMN phosphate also increases interactions between the protein scaffold and the FMN ribtyl side chain (Fig. 5) . We therefore propose that these added restrictions limit the dynamics of the FMN chromophore in iLOV and phiLOV and thus its ability to dissipate energy arising from light excitation.
Ser394 (Thr394 in iLOV) is conserved in the LOV1 and LOV2 domains of plant phototropins (27) . In contrast to the predominant light-sensing role of LOV2 (28), LOV1 shows minimal structural alterations upon photoexcitation (29, 30) and is proposed to mediate receptor dimerization (31, 32) . In our structures, Ser 394 forms a hydrogen bond with Asn401, directing the Ser hydroxyl away from the FMN ring. In the crystal structure of Arabidopsis phototropin 2 LOV1 (31), the corresponding serine (Ser138) cannot form this hydrogen bond, because the asparagine partner is replaced by cysteine (Cys145) (Fig. S7) . Instead, the serine hydroxyl is oriented towards the isoalloxazine ring, potentially forming tighter contacts with the FMN chromophore (Fig. S7) . Within this region, Thr394 in iLOV and phiLOV appears to incorporate the structural properties of both LOV1 and LOV2 by forming contacts with the isoalloxazine ring, whilst maintaining a hydrogen bond with Asn401 (Fig. 3C) .
The protein environment on the opposite side of the isoalloxazine ring in iLOV (Fig. 3C ) also resembles that in LOV1 (Fig. S7) , owing to the F470L mutation. Acquisition of LOV1-like residues in iLOV is not unexpected as both LOV1 and LOV2 sequences were included in the DNA shuffling procedure (3) . As a consequence of the F470L mutation, light-induced structural changes in LOV2 are markedly reduced and become minimal like those associated with LOV1 (33) . In this regard, directed evolution appears to have targeted regions of the LOV-core that are important for LOV2 signal transmission (30, 34) , but are dispensable for fluorescent reporter function.
Although iLOV exhibited reduced photobleaching in vivo compared to its predecessors (3), we showed that it was still amenable to improvements by our photostability selection method (Fig. 6) . Consistent with previous reports, photobleaching in vivo is reversible and likely correlates with the formation of a nonfluorescent neutral semiquinone species (3). High light intensities induce the formation of a neutral flavin semiquinone in LOV domains in which the photoactive cysteine has been mutated (35, 36) . Flavin semiquinone formation has been proposed to involve intraprotein electron transfer between a conserved tryptophan residue within the LOV domain and the FMN chromophore (35) . However, mutation of the corresponding tryptophan residue in iLOV (Trp467) to arginine, a mutation identified in phiLOV1.6 (Fig. S3) had no impact on fluorescence photobleaching in liquid cultures of E. coli (Fig. S4A) , indicating the presence of an alternative electron donor pathway.
Under the conditions used in our analysis (~0.1-0.2 W/cm 2 ), enhancements in FP photostability usually qualitatively predict improved performance under conditions typicalfor laser scanning microscopy (37) . Spectral shifts in fluorescence emission of up to 10 nm were detected during the selection method for phiLOV1.3 and phiLOV1.6 (Fig. S2 ). Both these variants contain the Q489L substitution (Fig. S3) shown previously to account for this spectral property (30, 34) . However, spectral shifting beyond this range is unlikely, as fluorescence emission of the protein is dictated by the FMN chromophore.
Structural characterization of phiLOV2.1 revealed the potential for further modifications within the PAS/LOV-fold that can positively impact the fluorescent properties of this domain (Fig. 8) . The structures presented here are relevant to the newly engineered singlet oxygen generator known as miniSOG, which was also derived from the LOV2 domain of Arabidopsis phototropin 2 (5). Four of the five mutation sites in miniSOG are virtually identical to the mutations present in iLOV (Fig. S8: S394T, S409G , C426G, F470L in miniSOG compared to S394T, S409G, C426A, F470L in iLOV). The fifth mutation in miniSOG, N390S, is present in all phiLOV2 variants (Fig.  S5) . The N390S mutation, as well as the N401Y mutation found in phiLOV2.1, had a significant impact on iLOV photostability in vivo (Fig. S4A) . Ser390 tethers the neighboring FMN-interacting side chain of Gln489, which in WT rotates 180° following photoexcitation to propagate structural changes at the β-sheet surface important for signaling (30, 34, 38) . In phiLOV2.1 and miniSOG (5), Ser390 restricts Gln489, thus providing additional, indirect anchoring and rigidifying of the FMN chromophore.
Further optimization of the selection method used here and for other FPs (37) could yield additional improvements in photostability. In this regard, our work highlights a structural framework and new amino acid targets suitable for saturation mutagenesis. Notably, LOV domains are widespread throughout nature and are found in organisms adapted to a diverse range of habitats (39) . These represent, as yet, untapped sources of sequence diversity that could be used to further enhance the properties of genetically encoded LOV FPs for specific cell and biological applications. Superposition of the FMN of iLOV (green), WT (pale blue) and C426A (orange) reveals that the isoalloxazine ring is tilted and undergoes some 'rotation' compared that of WT and C426A. In addition the phosphoribityl tail of iLOV appears to 'swing' and is shifted within the LOV-scaffold. Compared to WT (B), the terminal phosphate of the FMN in iLOV (C) is tightly packed by two salt bridges that comprise two highly conserved arginine residues, Arg427 and Arg443 respectively. 
